BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
Cantor Fitzgerald
Fuji
Deloitte
Fish and Richardson
Express Scripts
Julphar
Cipla
Cerilliant
Teva

Generated: January 17, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,048,859

« Back to Dashboard

Summary for Patent: 6,048,859
Title: Morpholine and thiomorpholine tachykinin receptor antagonists
Abstract:Substituted heterocycles of the general structural formula: ##STR1## are tachykinin receptor antagonists useful in the treatment of inflammatory diseases, pain or migraine, asthma and emesis, and calcium channel blockers useful in the treatment of cardiovascular conditions such as angina, hypertension or ischemia.
Inventor(s): Dorn; Conrad P. (Plainfield, NJ), Finke; Paul E. (Milltown, NJ), Hale; Jeffrey J. (Westfield, NJ), Maccoss; Malcolm (Freehold, NJ), Mills; Sander G. (Woodbridge, NJ), Shah; Shrenik K. (Metuchen, NJ), Chambers; Mark Stuart (Harts, GB), Harrison; Timothy (Great Dunmow, GB), Ladduwahetty; Tamara (Buckhurst Hill, GB), Williams; Brian John (Great Dunnow, GB)
Assignee: Merck & Co., Inc. (Rahway, NJ)
Application Number:09/251,190
Patent Claim Types:
see list of patent claims
Use;

Drugs Protected by US Patent 6,048,859

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 6,048,859

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Croatia P931003 ➤ Subscribe
Hungary 9403804 ➤ Subscribe
Hungary 219713 ➤ Subscribe
Hungary T71809 ➤ Subscribe
Croatia P941000 ➤ Subscribe
Hong Kong 1009268 ➤ Subscribe
Greece 3034095 ➤ Subscribe
Hong Kong 1009046 ➤ Subscribe
Finland 109532 ➤ Subscribe
Finland 946133 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Baxter
Johnson and Johnson
Federal Trade Commission
Cerilliant
Citi
Julphar
Harvard Business School
Boehringer Ingelheim
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot